Cell Culture Media Market Size, Share & Trends Analysis Report By Product (Serum-free Media, Stem Cell Culture Media), By Type (Liquid Media, Semi-solid And Solid Media), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

Research Methodology

A three-pronged approach was followed for deducing the cell culture media market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for cell culture media market to gather the most reliable and current information possible.

• We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
• We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
• We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
• We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
• We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of cell culture media market data depending on the type of information we’re trying to uncover in our research.

• Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

• Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

• Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

• Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

• Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

• Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

• This step also entails the finalization of the report scope and data representation pattern.

• Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Cell Culture Media Market Categorization:

The cell culture media market was categorized into five segments, namely product (Serum-free Media, Classical Media, Stem Cell Culture Media, Specialty Media, Chemically Defined Media, Other Cell Culture Media), application (Biopharmaceutical Production, Diagnostics, Drug Screening And Development, Tissue Engineering And Regenerative Medicine), type (Liquid Media, Semi-solid And Solid Media), end-use (Pharmaceutical And Biotechnology Companies, Hospitals And Diagnostic Laboratories, Research And Academic Institutes), and regions (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).

Segment Market Methodology:

The cell culture media market was segmented into product, application, type, end-use, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

• Demand estimation of each product across countries/regions summed up to from the total market.

• Variable analysis for demand forecast.

• Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

• Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

• Used extensively for new product forecasting or analyzing penetration levels.

• Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

• Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

• This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The cell culture media market was analyzed at a regional level. The global was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S.; Canada; Germany; the UK; France, Italy, Spain, Denmark, Sweden, Norway, China; Japan; India, South Korea, Australia, Thailand, Brazil; Mexico, Argentina, South Africa; Saudi Arabia, UAE, Kuwait.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Cell culture media market companies & financials:

The cell culture media market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

• Sartorius AG, Sartorius AG is a global entity that functions in two functioning divisions: Lab Products and Services and Bioprocess Solutions. In recent years, the Lab Products and Services division has increasingly served the rapidly expanding biopharmaceutical sector. This division, with its offerings, caters to biotech and pharmaceutical research labs as well as academic research institutions. The company provides consumables and instruments to researchers and lab personnel. Sartorius AG has subsidiary companies in over 30 countries, including the U.S., Germany, Russia, Brazil, China, India, and Israel. Additionally, in 2021, the company invested approximately USD 421.55 million to enhance the competencies of numerous product segments and all business areas.

• Danaher Corporation, Operating globally, Danaher Corporation is a producer and distributor of products and services in the industrial, medical, and commercial sectors. The company’s offerings are primarily divided into three categories: Diagnostics, Life Sciences, and Environmental & Applied Solutions. The Life Sciences division provides technologies for separation, filtration, and purification in various areas, including biopharmaceuticals, medical research, and food & beverage. Additionally, it supplies reagents, consumables, analytical instruments, and services to hospitals, laboratories, and other healthcare facilities. Subsidiaries of Danaher include Beckman Coulter, Inc., Leica Biosystems, and HemoCue.

• Merck KGaA, Merck KGaA, a multinational corporation based in Germany, provides healthcare solutions and materials. It functions through three divisions: healthcare, life sciences, and performance materials. The company has a presence in North America, Europe, Asia, Latin America, Oceania, and Africa. It provides products for biopharma, consumer health, allergopharma, biosimilars, life sciences, and performance materials. Merck declared the purchase of Sigma-Aldrich Co. LLC, which started functioning as a subsidiary, in november 2015.

• Thermo Fisher Scientific, Inc., Thermo Fisher Scientific, Inc. is a producer and supplier of laboratory reagents, equipment, analytical instruments, consumables, and diagnostic products. The company functions under brands like Thermo Scientific, Applied Biosystems, Fisher Scientific, Invitrogen, and Unity Lab Services. It has four main segments: Analytical Instruments, Life Sciences Solutions, Specialty Diagnostics, and Laboratory Products & Services. The life sciences solutions segment comprises four businesses: Clinical Next-Generation Sequencing, Biosciences, BioProduction, and Genetic Sciences. The bioscience segment offers products such as cell culture media, reagents, consumables, and instruments that help customers in piloting medical and biological research and determining new vaccines and drugs. The business caters to pharmaceutical and biotechnology companies, government agencies, clinical diagnostics laboratories, hospitals, and research associations.

• FUJIFILM Irvine Scientific, Inc, FUJIFILM Irvine Scientific, Inc., is a worldwide pioneer in the production and innovation of medical devices, reagents, and cell culture media for researchers and clinicians. The company caters to scientists engaged in regenerative medicine, cell therapy and biopharmaceuticals, cytogenetics, assisted reproductive technology, and industrial cell culture for the production of large-scale vaccines and biotherapeutics. It functions as a subsidiary of FUJIFILM Holdings America Corporation and reports to FUJIFILM Holdings Corporation.

• Lonza, Lonza is a worldwide entity in the biotech, nutrition pharmaceuticals sectors. The firm offers an extensive array of services and products via four divisions: Lonza Small Molecules, Lonza Biologics, Lonza Cell & Gene Therapy, and Lonza Capsule & Health Ingredients. The firm has operations spanning five continents: North America, Europe, APAC, LATAM, and the Middle East & Africa.

• BD, BD is a firm specializing in medical technology, catering to clinical labs, researchers in life sciences, and various healthcare institutions & industries. The firm produces and sells a diverse array of medical devices, diagnostic items, medical supplies, and lab equipment. It functions through three divisions: BD Life Sciences, BD Medical, and BD Interventional. The BD Life Sciences division offers products for the secure gathering & transport of diagnostic samples and reagent systems & tools that precisely identify a wide spectrum of healthcare-related infections, infectious diseases, and cancer. Moreover, the business provides cell culture media products through its Microbiology solutions

• STEMCELL Technologies, STEMCELL Technologies provides cell separation technologies, supplementary products, superior cell culture media, devices, and educational resources to global researchers focusing on immunology, stem cells, cellular therapy research, cancer, and regenerative medicine. The firm aids life sciences research with over 2,500 definite reagents, services, and tools. The firm has direct sales and backing in 25 nations spanning Europe, North America, Australia, and Asia.

• Cell Biologics, Inc., Cell Biologics, Inc. is a premier producer of cell culture and primary cultured cell items. The firm offers over 2,000 superior animal and human primary cells sourced from healthy or diseased tissues, incorporating bone marrow cells, liver cells, endothelial, epithelial cells, stem cells & tumor cells, in addition to improved cell culture media, and other linked goods.

• PromoCell GmbH, PromoCell GmbH provides improved cell culture media, human primary, and blood cells, along with stem cells. Its main users are worldwide researchers involved in fields such as cancer research, cardiovascular research, cosmetics & dermatology, COVID-19 research, diabetes & obesity, immuno-oncology, immunology, respiratory research, stem cells & regenerative medicine, and 3D cell culture. The business's offerings obey to European biomedical standards. It has operations in more than 40 countries worldwide.

Value chain-based sizing & forecasting

Supply Side Estimates

• Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

• Segment revenue determination via variable analysis and penetration modeling.

• Competitive benchmarking to identify market leaders and their collective revenue shares.

• Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

• Identifying parent markets and ancillary markets

• Segment penetration analysis to obtain pertinent

• revenue/volume

• Heuristic forecasting with the help of subject matter experts

• Forecasting via variable analysis

Cell Culture Media Market Report Objectives:

• Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

• Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

• Understanding market estimates and forecasts (with the base year as 2023, historic information from 2018 to 2022, and forecast from 2024 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Cell Culture Media Market Report Assumptions:

• The report provides market value for the base year 2023 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

• The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

• We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

• All market estimates and forecasts have been validated through primary interviews with the key industry participants.

• Inflation has not been accounted for to estimate and forecast the market.

• Numbers may not add up due to rounding off.

• Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

• Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

• Latin America includes Central American countries and the South American continent

• Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

• Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

• Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.